ClinVar Miner

Submissions for variant NM_003060.4(SLC22A5):c.652+6=

dbSNP: rs4551059
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000080057 SCV000111952 benign not specified 2017-12-07 criteria provided, single submitter clinical testing
GeneDx RCV000080057 SCV000171658 benign not specified 2013-05-29 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Illumina Laboratory Services, Illumina RCV000022335 SCV000452730 benign Renal carnitine transport defect 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000022335 SCV000605128 benign Renal carnitine transport defect 2020-04-13 criteria provided, single submitter clinical testing
Phosphorus, Inc. RCV000022335 SCV000679882 benign Renal carnitine transport defect 2017-08-01 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000588754 SCV000698152 benign not provided 2016-04-18 criteria provided, single submitter clinical testing Variant summary: The SLC22A5 c.652+6A>G variant affects a non-conserved intronic nucleotide. Mutation Taster predicts a polymorphism outcome for this variant, and 5/5 Alamut algorithms predict not significant change to splicing. This variant was found in homozygous state in all 121410 control chromosomes from ExAC suggesting that nucleotide G is the ancestral allele at this cDNA position. Additionally, this variant has been reported to co-occur in a CDSP patient with potentially pathogenic SLC22A5 variants T440M (c.1319C>T) and F23del (c.67_69delTTC) that were in compound heterozygous state, indicating that this variant was not a causal variant. In addition, multiple clinical laboratories have classified this variant as benign. Taken together, this variant has been classified as Benign.
Invitae RCV000022335 SCV001728988 benign Renal carnitine transport defect 2024-02-01 criteria provided, single submitter clinical testing
Pars Genome Lab RCV000022335 SCV001738689 benign Renal carnitine transport defect 2021-06-15 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000022335 SCV002055871 benign Renal carnitine transport defect 2021-07-15 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.